Grado, M.D. v. Medical, Industrial, and Scientific Products Corporation

CourtDistrict Court, S.D. Ohio
DecidedOctober 31, 2024
Docket1:24-cv-00158
StatusUnknown

This text of Grado, M.D. v. Medical, Industrial, and Scientific Products Corporation (Grado, M.D. v. Medical, Industrial, and Scientific Products Corporation) is published on Counsel Stack Legal Research, covering District Court, S.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Grado, M.D. v. Medical, Industrial, and Scientific Products Corporation, (S.D. Ohio 2024).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF OHIO WESTERN DIVISION

GORDON GRADO, M.D., et al.,

Plaintiffs, Case No. 1:24-cv-158 v. JUDGE DOUGLAS R. COLE MEDICAL, INDUSTRIAL, AND SCIENTIFIC PRODUCTS CORPORATION, et al.,

Defendants. OPINION AND ORDER Plaintiffs Gordon Grado, M.D., and Centro de Especialidad Oncologica (CdEO), have sued Defendants Jordan Medical Group, LLC, (JMG), and its president Suleiman A. Refaei, as well as Medical, Industrial, and Scientific Products Corporation (MIS), and its president Jose Rodriguez in tort and contract for Defendants’ failure to deliver a linear accelerator machine (LINAC). JMG and Refaei have moved to dismiss claiming that (1) the res judicata effect of a prior judgment in a different suit that MIS (the other defendant here) prosecuted against them involving the same transaction bars CdEO’s current claims against them, (2) CdEO lacks standing to sue, and (3) Refaei is not a proper defendant. For the reasons explained below, the Court concludes that CdEO has standing to sue, Grado and CdEO have alleged valid claims against Refaei, and that several of these claims are not precluded based on the prior MIS and Rodriguez suit (although others are). As a result, the Court GRANTS IN PART AND DENIES IN PART JMG’s and Refaei’s Motion to Dismiss for Failure to State a Claim (Doc. 20). Specifically, the Court DISMISSES WITH PREJUDICE the promissory estoppel (Count IV), unjust enrichment (Count V), trespass to chattel (Count VI), and

conversion (Count VII) claims in the Amended Complaint (Doc. 11) against JMG and Refaei. BACKGROUND1 Grado owns and operates CdEO, a Mexican company running oncology centers in Mexico. Grado sought to obtain a LINAC machine to help treat CdEO’s cancer

patients. (Doc. 11 ¶¶ 1–2, 9–10, 30, #73–74, 78). In the past, Grado tried to work with JMG and Refaei as a source for fulfilling his medical equipment needs. (Id. ¶ 16, #76). But JMG and Refaei had proven unreliable. (Id. ¶ 17, #76). So Grado instead contracted with MIS and Rodriguez for a LINAC machine, based on Rodriguez’s representation to Grado and CdEO that MIS owned a LINAC in good working condition that it could deliver immediately upon sale. (Id. ¶¶ 11, 13, #75; Doc. 11-1).2 Unbeknownst to Grado and CdEO, MIS and Rodriguez instead were acting as

brokers for JMG and Refaei. That is, MIS and Rodriguez were planning to sell JMG’s and Refaei’s LINAC machine to Grado (who would then in turn transfer it to his

1 Because this matter comes before the Court on a motion to dismiss, the Court must accept the well-pleaded allegations in the Complaint as true. Bassett v. Nat’l Collegiate Athletic Ass’n, 528 F.3d 426, 430 (6th Cir. 2008). But in reporting the background here based on those allegations, the Court reminds the reader that they are just that—allegations. 2 Plaintiffs attached this contract (and two others) to their pleadings. Though the Court must generally confine its review to just the allegations at the motion-to-dismiss stage, it may still rely on these documents because they are written instruments that are expressly referenced in the Amended Complaint and that serve as the basis for Plaintiffs’ claims. Anderson v. ABF Freight Sys., Inc., No. 1:23-cv-278, 2024 WL 51255, at *1 n.3 (S.D. Ohio Jan. 4, 2024); Fed. R. Civ. P. 10(c). company CdEO). (Doc. 11 ¶¶ 12, 20–26, #75–77). To accomplish this one-two, MIS and Rodriguez signed a purchase agreement with JMG and Refaei that governed the sale of the LINAC from JMG (and Refaei) to MIS (and Rodriguez), and another

agreement where JMG and MIS agreed with each other that they had “joined efforts to sell a [LINAC] to … Grado … for a project in the city of Aguascalientes[,] [] Mexico”—the new oncology clinic Grado and CdEO planned to open. (Id. ¶¶ 2, 24–25, #73, 77; Docs. 11-2, 11-3); see supra note 2. Defendants’ joint venture to sell a LINAC to Grado occurred despite Grado’s expressly informing MIS and Rodriguez that he did not want to do any further business with JMG and Refaei. (Doc. 11 ¶¶ 18–19,

#76). In any event, based on MIS’s and Rodriguez’s (mis)representing that they owned the LINAC they were selling, Grado executed a purchase agreement with MIS to personally purchase the LINAC and paid the full price for it. Grado’s plan was to transfer the LINAC to CdEO when it was delivered to him. (Id. ¶¶ 13–15, 30, #75, 78; Doc. 11-1). MIS and Rodriguez accepted these payments and paid some of the funds to JMG and Refaei. (Doc. 11 ¶ 27, #77). Rather than deliver the LINAC as agreed, though, JMG and Refaei sought

another $25,000 (though the Amended Complaint does not make clear of whom they demanded this additional payment). (Id. ¶ 28, #77). And not only did no Defendant deliver the LINAC to Grado or CdEO, but no one refunded any money either. (Id. ¶ 29, #77). As a result, Grado and CdEO allege that (1) they had to buy another LINAC to replace the one they were to receive under their contract with MIS and Rodriguez, and (2) the delay in obtaining that replacement machine caused Grado and CdEO to lose business and clientele. (Id. ¶ 30, #78). For these harms, on March 25, 2024, Grado and CdEO brought this action

raising several contract and tort claims against all four Defendants.3 (Compl., Doc. 1). Against MIS and Rodriguez (the counterparties to Grado’s contract) alone, Grado and CdEO raised claims for breach of contract (Count I), fraudulent inducement (Count II), and negligent misrepresentation (Count III). (Id. ¶¶ 31–49, #78–81). Against all four Defendants, Grado and CdEO raised claims for promissory estoppel (Count IV), unjust enrichment (Count V), fraudulent misrepresentation over the

proper ownership of the LINAC machine (Count VIII), and civil conspiracy (Count X). (Id. ¶¶ 50–59, 69–75, 82–85, #81–82, 84–85, 86–87). Against just JMG and Refaei (the LINAC owners, but parties with whom Grado had no direct contract), Grado and CdEO raised claims of trespass to chattel (Count VI), conversion (Count VII), and tortious interference with contract (Count XI). (Id. ¶¶ 60–68, 86–90, #82–84, 87). And finally, against MIS, Rodriguez, and JMG, Grado and CdEO raised a breach-of- contract claim (Count IX) for Defendants’ breach of the agreement recognizing Grado

as the third-party beneficiary of the transfer of the LINAC from JMG and Refaei to MIS and Rodriguez. (Id. ¶¶ 76–81, #85–86).

3 Four days after filing suit and before any party had been served, Plaintiffs amended their Complaint under Rule 15(a)(1) by filing the operative Amended Complaint. (Doc. 11). MIS and Rodriguez have just recently been served. (Docs. 30, 31). But JMG and Refaei were served some months back, (Docs. 16, 17), and they have moved to dismiss. (Doc. 20).

Their main argument turns on their belief that this suit fails due to the res judicata effect of a judgment in a prior contract action that MIS (the company acting as the middleman) brought against JMG and Refaei (who actually owned the LINAC).4 (Id. at #117). That MIS suit, which the company filed on July 29, 2021, arose out of the same set of facts and involved several contract and tort claims arising out of JMG’s and Refaei’s failure to deliver the LINAC to MIS as agreed in the

contract between them. (Compl., Med., Indus. & Sci. Prods., Inc. v. Jordan Med. Grp., LLC, No. 1:21-cv-555 (S.D. Ohio Aug. 27, 2021), Doc. 2). After some initial motions practice (that never resulted in a ruling), the Court dismissed with prejudice MIS’s action against JMG and Refaei for failure to prosecute per Federal Rule of Civil Procedure 41(b).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Sprint Communications Co. v. APCC Services, Inc.
554 U.S. 269 (Supreme Court, 2008)
Taylor v. Sturgell
553 U.S. 880 (Supreme Court, 2008)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
John H. Hapgood v. City of Warren
127 F.3d 490 (Sixth Circuit, 1997)
Thomas M. Klepsky v. United Parcel Service, Inc.
489 F.3d 264 (Sixth Circuit, 2007)
Delay v. Rosenthal Collins Group, LLC
585 F.3d 1003 (Sixth Circuit, 2009)
Bassett v. National Collegiate Athletic Ass'n
528 F.3d 426 (Sixth Circuit, 2008)
Steel Co. v. Citizens for a Better Environment
523 U.S. 83 (Supreme Court, 1998)
Semtek International Inc. v. Lockheed Martin Corp.
531 U.S. 497 (Supreme Court, 2001)
State v. Harding
2014 Ohio 1187 (Ohio Court of Appeals, 2014)
Toll Bros Inc v. Century Surety Co
318 F. App'x 107 (Third Circuit, 2009)
Cranpark, Inc. v. Rogers Group, Inc.
821 F.3d 723 (Sixth Circuit, 2016)
Berge v. Columbus Community Cable Access
736 N.E.2d 517 (Ohio Court of Appeals, 1999)
Crittendon v. Crittendon
612 N.E.2d 759 (Ohio Court of Appeals, 1992)
Laurent v. Flood Data Services, Inc.
766 N.E.2d 221 (Ohio Court of Appeals, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
Grado, M.D. v. Medical, Industrial, and Scientific Products Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/grado-md-v-medical-industrial-and-scientific-products-corporation-ohsd-2024.